Related Experiment Videos
[Neonatal primary hyperparathyroidism caused by clear cell hyperplasia]
Insights
Neonatal primary hyperparathyroidism, a rare condition, presents with respiratory distress and hypercalcemia. Early diagnosis via parathyroid hormone levels and timely surgery can lead to successful long-term outcomes.
Area of Science:
- Pediatric Endocrinology
- Surgical Neonatology
- Biochemistry
Background:
- Neonatal primary hyperparathyroidism is an uncommon endocrine disorder.
- It requires prompt recognition due to potential severe complications.
Observation:
- The case presented with respiratory distress, thoracic deformity, and hypercalcemia.
- Diagnosis was confirmed by elevated plasma immunoreactive parathyroid hormone levels.
- The patient exhibited vitamin D deficiency rickets prior to surgical intervention.
Findings:
- Diffuse hyperplasia of water-clear cells was identified as the cause.
- A significant parathyroidectomy (7/8 glands) was successfully performed.
- The child achieved normocalcemia, sustained for two years post-surgery.
Implications:
- This case highlights the importance of considering neonatal primary hyperparathyroidism in infants with specific clinical signs.
- Early diagnosis and surgical management are crucial for normalizing calcium levels and preventing long-term complications.
- The timing of surgical intervention should be guided by the severity of hypercalcemia.
Abstract:
Neonatal primary hyperparathyroidism is rare but must be evoke during respiratory distress with thoracic deformity and hypercalcemia. The plasma immunoreactive parathyroid hormone level allows the diagnostic. This case, with diffuse hyperplasia of water-clear cells type, develops rickets of vitamin D deficiency before surgery. A large parathyroidectomy (7/8) was performed and the child is normo-calcemic 2 years after. The time of surgery is function of calcium level.